ReInnervate
Pioneering tools for advancing stem cell research and developing vital diagnostics and treatments for neuro-degenerative diseases.
Pioneering tools for advancing stem cell research and developing vital diagnostics and treatments for neuro-degenerative diseases.
ReInnervate Limited, a pioneer in developing tools for advancing stem cell research and vital diagnostics and treatments for neurodegenerative diseases, has been making significant strides in the biotechnology and healthcare industries. Founded in 2002 and headquartered in Durham, United Kingdom, the company has garnered attention for its innovative technologies that drive research in cell growth and function in vitro, particularly within stem cell biology. The solutions provided by ReInnervate facilitate the differentiation of stem cells and the development of specific tissue types, as well as offer tools for creating diagnostics and treatments for neurodegenerative diseases. In 2014, the company received a £100.00KVenture Round investment from Northstar Ventures, signifying the confidence investors have in ReInnervate's potential to make a significant impact in the biotechnology and healthcare sectors. With a strong focus on technological innovation and a commitment to advancing research and development in crucial areas such as neurodegenerative diseases, ReInnervate is poised to play a significant role in shaping the future of healthcare and biotechnology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | £100.00K | 1 |
|
28 May 2014 |
| Venture Round | £1.09M | 2 |
|
30 Jan 2013 |
| Series B | £2.07M | 2 |
|
22 Dec 2011 |
| Series A | £1.57M | 1 |
|
26 Apr 2010 |
No recent news or press coverage available for ReInnervate.
We care about your data, and we'd love to use cookies make your experience better.
